Form 4/A for HIMS Hims & Hers Health, Inc.
Accepted 2023-12-15 00:00:00 ET · period of report 2023-11-30 · accession 0001773751-23-000289 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2023-12-15 | 2023-11-30+ | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale+OE | $9.03 | -28.1K | 0 | -100% | -$253.7K |
| DMA | 2023-12-15 | 2023-11-30+ | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $2.43 | +28.1K | 3,800 | New | +$68.3K |
| DMA | 2023-12-15 | 2023-11-30+ | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $0.00 | -28.1K | 2.99M | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-01 | S | D | 24,300 | $9.03 | 0 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2023-12-01 | M | A | 24,300 | $2.43 | 24,300 | D | — | — | |
| 3 | Common | Class A Common Stock | 2023-11-30 | S | D | 3,800 | $9.01 | 0 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2023-11-30 | M | A | 3,800 | $2.43 | 3,800 | D | — | — | (F2) Shares of Class A Common Stock were previously reported as directly beneficially owned, but all such shares were previously transferred to the Dudum Family Community Property Trust. |
| 5 | Derivative | Stock Option (right to buy) | 2023-11-30 | M | D | 3,800 | $0.00 | 3,012,064 | D | $2.43 · — to 2030-06-17 | 3,800 Class A Common Stock | (F12) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. |
| 6 | Derivative | Stock Option (right to buy) | 2023-12-01 | M | D | 24,300 | $0.00 | 2,987,764 | D | $2.43 · — to 2030-06-17 | 24,300 Class A Common Stock | (F12) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. |